Testis Cancer: Clinical Trials

1 trial for Testis Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Testis Cancer: new trials by email Literature Review of Testis Cancer trials Research Report on Testis Cancer

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
Brentuximab Vedotin - Germ Cell Tumors, Testis Cancer
Phase 2TerminatedNabil Adra182016-03-092019-12-10

Narrower conditions

Carcinoma, Embryonal (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Nonseminomatous germ cell tumor (1)  ·  Testicular Neoplasms (1)

Broader conditions

Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Genital Neoplasms, Male (1)  ·  Gonadal Disorders (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Testicular Diseases (1)  ·  Urogenital Diseases (1)  ·  Urogenital Neoplasms (1)

Interventions

Brentuximab Vedotin (1)

Sponsors

Nabil Adra (1)

Countries

United States (1)

Top investigators

Costantine Albany, MD (1)